Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.82 USD | +2.86% |
|
-31.83% | -1.91% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -9.29x | - | -0.04x | - | - | - | - | 1.3B | |
| 32.9x | 4.38x | 1.26x | 5.88x | 17.49x | 24.61x | 0.97% | 48.22B | |
| -22.77x | 17.85x | -0.66x | 340.62x | -20.81x | -20.73x | -.--% | 38.79B | |
| 29.98x | 5.49x | -42.25x | 3x | 12.95x | 19.74x | -.--% | 38.41B | |
| 46.6x | 7.01x | 0.28x | 4.72x | 30.74x | 35.29x | -.--% | 34.88B | |
| 27.72x | 2.25x | 0.58x | 8.03x | 20.18x | 24.04x | 0.42% | 29.19B | |
| 32.6x | 23.39x | 2.16x | 5.33x | 24.22x | 25.33x | -.--% | 16B | |
| 22.53x | 2.53x | 0.65x | 1.98x | 8.57x | 13.14x | 1.17% | 13.53B | |
| 24.75x | 1.27x | 0.21x | 1.81x | 11.1x | 12.64x | -.--% | 12.22B | |
| 60.62x | 5.18x | 0.38x | 9.25x | 26.27x | 28.69x | 0.44% | 11.24B | |
| 37.66x | 3.37x | -0.12x | 3.36x | 13.06x | 15.89x | -.--% | 11.12B | |
| -30.26x | 8.9x | 1.14x | 108.74x | -30.95x | -53.86x | -.--% | 10.64B | |
| -31.07x | 8.99x | -13.65x | 999.82x | -26.51x | -25.97x | -.--% | 10.07B | |
| 33.61x | 3.7x | 2.36x | 3.94x | 16.87x | 25.8x | 0.67% | 8.92B | |
| 31.14x | - | -0.1x | 14.97x | 27.76x | 27.92x | -.--% | 8.51B | |
| -15.35x | 630.82x | -0.31x | 9.41x | -14.98x | -14.51x | -.--% | 9.06B | |
| -20.09x | 7.61x | -1.57x | 3439.14x | -16.9x | -16.46x | -.--% | 8.52B | |
| 19.71x | 2.31x | 1.84x | 4.38x | 11.52x | 15x | -.--% | 8.75B | |
| -28.59x | 7.36x | 5.82x | 80.9x | -18.24x | -17.73x | -.--% | 8.25B | |
| Average | 12.76x | 43.67x | -2.21x | 280.29x | 5.13x | 6.60x | 0.2% | 17.24B | |
| Weighted average by Cap. | 18.51x | 25.24x | -4.79x | 170.86x | 8.38x | 11.21x | 0.26% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
